← Evidence map

ArticleCPT: pharmacometrics & systems pharmacology2025

Continuous-Time Markov Population PK/PD Modeling of Longitudinal EASI Categorical Score in Atopic Dermatitis Treated With Rocatinlimab, an Anti-OX40 Monoclonal Antibody.

Hiroki Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 40660464